🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Purple Day is coming up! 💜 Let's help raise epilepsy awareness this month. Kicking things off, learn more about the Purple Day Expo 2025 hosted by @EpilepsyAssoc, happening tomorrow! 🔗purpledayeveryday.org/events/purpled… #EpilepsyAwareness #PurpleDay #XenonPharma

We are looking forward to presenting at the Stifel Virtual CNS Forum on Wednesday, March 19, 2025. Details and webcast link here: investor.xenon-pharma.com/news-releases/…

Tomorrow, our team is joining the Epilepsy Foundation of America’s National Epilepsy Walk to support those living with epilepsy and advance research for better treatments. Join a walk near you: walktoendepilepsy.org/locations/ #WalkToEndEpilepsy

Team Xenon joined the purple wave and walked with purpose at the #NationalEpilepsyWalk in DC this past Saturday. A heartfelt thank you to Epilepsy Foundation of America for organizing this event to raise awareness and further the fight against epilepsy. #EpilepsyAwareness #XenonPharma

Epilepsy is the fourth most common neurological disorder in the world, yet it’s still misunderstood. Let’s raise awareness and break the stigma. Learn more about upcoming Purple Day: purpleday.org 💜 #EpilepsyAwareness #SeizureEducation #XenonPharma #PurpleDay

Today is Purple Day! 💜 Join us in wearing purple today and supporting events to raise epilepsy awareness. More details: purpleday.org #EpilepsyAwareness #PurpleDay #XenonPharma

Did you know? In approximately 30% of people with epilepsy, seizures cannot be controlled with anti-seizure medications currently available. Let’s raise awareness about epilepsy. Learn more: purpleday.org #EpilepsyAwareness #SeizureEducation #XenonPharma #PurpleDay

We are looking forward to presenting three posters at the upcoming American Academy of Neurology meeting taking place in San Diego, CA! More details here: investor.xenon-pharma.com/news-releases/… #XenonPharma #epilepsy #biotech #neurology #AAN2025

Join us today at #AAN2025 for our poster presentation exploring the mental health burden of epilepsy in patients with focal onset seizures from 11:45 AM - 12:45 PM PT. #XenonPharma #biotech #epilepsyresearch

Today we presented two posters at #AAN2025. Find the Xenon team at Booth #1110 in the Exhibit Hall! #XenonPharma #focalonsetseizure #biotech #epilepsyresearch

That’s a wrap on #AAN2025! Thank you to everyone who stopped by to learn more about our work and to our team for representing Xenon while sharing our scientific posters and connecting in person with the broader neurology community. #XenonPharma #biotech #neurology

We will report our first quarter results on Monday, May 12th. Join us for a webcast beginning at 4:30 pm ET. More details here: investor.xenon-pharma.com/news-releases/…

Xenon Reports First Quarter 2025 Financial Results and Provides Business Update Read more: ow.ly/i8Br50VRpbI #neuroscience #ionchannel #epilepsy #MDD #BPD

We are looking forward to presenting at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET on Wednesday, May 21, 2025. Details and webcast link here: investor.xenon-pharma.com/news-releases/…

Today! 📅 We are looking forward to presenting at the 2025 RBC Capital Markets Global Healthcare Conference at 10:30 am ET. Details and webcast link here: investor.xenon-pharma.com/news-releases/…

We’re proud to share a new publication in JAMA Network Open that highlights the Phase 2 X-NOVA clinical trial results in MDD. The article is now available here: jamanetwork.com/journals/jaman… #XenonPharma #Neuroscience #MDDResearch #MajorDepressiveDisorder #ClinicalResearch

Team Xenon was proud to walk together this past Sunday at the Epilepsy Foundation of America New England Walk for Epilepsy in Boston. With every step, we honored the resilience of the epilepsy community and reaffirmed our commitment to advancing research that makes a difference.

We look forward to presenting next week at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10th. Details and webcast link here: investor.xenon-pharma.com/news-releases/…

Today! 📅 We are looking forward to presenting at the Goldman Sachs 46th Annual Global Healthcare Conference at 3:20 pm ET. Details and webcast link here: investor.xenon-pharma.com/news-releases/…

We’re excited to welcome Darren Cline as #XenonPharma’s Chief Commercial Officer. He’ll lead commercial strategy across our portfolio, with an initial focus on our first potential launch in #epilepsy. investor.xenon-pharma.com/news-releases/…